StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.70−0.48 (-5.87%)

Close on Nov 16, 2026Market cap $697.34MP/E –Yield –

Verastem profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Verastem's profit margin for the twelve months ending Sep 30, 2026 was -178.4%. For fiscal 2025 it was -677.6%, against -1306.4% the year before. The highest annual figure on record is -76.5% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-677.6%+628.8
FY2024Dec 31, 2024-1306.4%+1536.9
FY2022Dec 31, 2022-2843.3%+624.8
FY2021Dec 31, 2021-3468.1%−3391.6
FY2020Dec 31, 2020-76.5%+778.3
FY2019Dec 31, 2019-854.8%−583.7
FY2018Dec 31, 2018-271.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-311.2%+565.1
Q2 FY2026Jun 30, 2026-86.5%+1127.1
Q1 FY2026Mar 31, 2026-196.0%+225.2
Q4 FY2025Dec 31, 2025-187.7%+465.7
Q3 FY2025Sep 30, 2025-876.3%+2147.7
Q2 FY2025Jun 30, 2025-1213.6%+1138086.4
Q1 FY2024Jun 30, 2024-421.2%+2959.2
Q1 FY2022Mar 31, 2022-653.4%+840.7
Q4 FY2021Dec 31, 2021-3024.0%+901.7
Q3 FY2021Sep 30, 2021-1139300.0%−1139316.7
Q2 FY2021Jun 30, 2021-3380.4%−2846.2
Q1 FY2021Mar 31, 2021-1494.1%−742.8
Q4 FY2020Dec 31, 2020-3925.7%−2853.7
Q3 FY2020Sep 30, 202016.7%+350.4
Q2 FY2020Jun 30, 2020-534.2%+811.2
Q1 FY2020Mar 31, 2020-751.4%+1528.8
Q4 FY2019Dec 31, 2019-1072.0%−134.1
Q3 FY2019Sep 30, 2019-333.7%−194.0
Q2 FY2019Jun 30, 2019-1345.5%−1161.8
Q1 FY2019Mar 31, 2019-2280.2%–
Q4 FY2018Dec 31, 2018-937.9%–
Q3 FY2018Sep 30, 2018-139.7%–
Q2 FY2018Jun 30, 2018-183.7%–

More Verastem figures

See a number that looks wrong?